Evasion Mechanisms to Igf1r Inhibition in Rhabdomyosarcoma

Inhibition of the insulin-like growth factor 1 receptor (Igf1r) is an approach being taken in clinical trials to overcome the dismal outcome for metastatic alveolar rhabdomyosarcoma (ARMS), an aggressive muscle cancer of children and young adults. In our study, we address the potential mechanism(s)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Abraham, Jinu, Prajapati, Suresh I., Nishijo, Koichi, Schaffer, Beverly S., Taniguchi, Eri, Kilcoyne, Aoife, McCleish, Amanda T., Nelon, Laura D., Giles, Francis G., Efstratiadis, Argiris, LeGallo, Robin D., Nowak, Brent M., Rubin, Brian P., Malempati, Suman, Keller, Charles
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4109806/
https://ncbi.nlm.nih.gov/pubmed/21447712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-10-0695
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares